resveratrol tagged posts

The largest nationwide clinical trial to study high-dose resveratrol long-term in people with mild to moderate Alzheimer’s disease found that a biomarker that declines when the disease progresses was stabilized in people who took the purified form of resveratrol. Resveratrol is a naturally occurring compound found in foods such as red grapes, raspberries, dark chocolate and some red wines.

The resveratrol clinical trial was a randomized, phase II, placebo-controlled, double blind study in 119 patients with mild to moderate dementia due to Alzheimer’s disease. An “investigational new drug” application was required by FDA to test the pure synthetic (pharmaceutical-grade) resveratrol in the study. It is not available commercially in this form...

Previous research looked at high doses of purified resveratrol to study its potential to prevent cancer. This is the first study to look at the effects of a lower daily dose – equivalent to the amount of resveratrol found in one large (approx. 250ml) glass of red wine vs dose 200X higher. Results from bowel cancer-prone mice given the smaller dose showed a 50% reduction in tumour size while the high dose showed a 25% reduction. Lower doses of resveratrol were twice as effective as the higher dose in stopping tumours growing, although this effect was only seen in animals fed a high-fat diet.

Samples of tumours from bowel cancer patients given different doses of resveratrol showed that even lower doses can get into cancer cells and potentially affect processes involved in tumour growth...